Astera Labs stock falls around 4.5% as ETFs post $15.3 million net outflow

Traders Union
All News
Stocks
Astera Labs drops 4.58% today

Highlights

ETFs recorded net outflows of $15.3 million in Astera Labs on October 8, indicating institutional selling of the stock.
Astera Labs reported trailing-12-month revenue of $1.20 billion, up 85.4% year over year, with gross margin at 75.1% and net margin at 30.7%.
Astera Labs stock trades below short-term averages with oscillators in oversold territory; next five-day range projected at $289.39 to $362.74.

Sustained selling despite strong fundamentals and alternating ETF flows

On October 8, ETFs were net sellers of Astera Labs with a total net outflow of $15.3 million, as more shares were sold than purchased across multiple funds. In previous sessions, net flows alternated, including a $4.3 million net inflow on October 7. Astera Labs reported trailing-12-month revenue of $1.20 billion, an 85.4% year-over-year increase, with a gross margin of 75.1% and a net margin of 30.7%. The company's market capitalization was $59.4 billion, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees Astera Labs exposed to persistent selling pressure driven by significant ETF outflows. He notes the technical weakness, with the stock trading below its 20-day moving average and sellers dominating momentum indicators like BBP and oversold oscillators. Kharitonov cautions that the sharp reversal despite strong year-over-year revenue hints at vulnerability, especially as net flows remain volatile and sentiment fragile. He highlights that support at $324.3 is critical, yet price action signals risk of further downside if selling intensifies. "Despite impressive fundamentals, I remain wary until momentum shifts decisively — further weakness below $324.3 would raise serious red flags for bulls."

Viktoras Karapetjanc, expert at Traders Union, views the short-term pressure as a normal setback in an otherwise bullish fundamental story. He emphasizes Astera Labs' rapid revenue growth and robust margins, which reinforce the long-term appeal despite recent ETF-driven outflows. Karapetjanc remains confident that the stock’s favorable structure above its 50-day and 200-day averages supports ongoing upside opportunities. He expects consolidation now, with high odds for a rally if resistance at $326.35 is reclaimed. "The bullish structure remains intact — further growth is likely as market flows stabilize and buyers return to quality tech leaders like Astera Labs."

Jainam Mehta, market strategist, observes mixed momentum and diverging technical signals for Astera Labs. He notes that the stock’s position between key moving averages offers tactical setups on both sides, with oversold oscillators hinting at a potential contrarian long if support at $324.3 holds. Mehta sees a tight volatility band and consolidation as a likely scenario for the near term. "A possible breakout above $326.35 could trigger a swift squeeze, but I'd monitor sentiment closely for contrarian trade setups around these levels."

Post-open pressure persists as mixed momentum meets technical support

Astera Labs is currently trading below its 20-day moving average at $338.11, but remains above both the 50-day at $317.48 and the 200-day at $246.37. This setup signals short-term seller pressure, medium-term support, and a bullish long-term structure, with the Ichimoku Kijun at $326.35 acting as near-term resistance and today’s low at $324.3 as immediate support. Momentum is mixed: the MACD shows strong buy pressure, while the ADX indicates neutral trend strength. The RSI is at 51.35 (forecast to buy), the Stochastic RSI is oversold, and the CCI is neutral. Bull/Bear Power (BBP) is negative at -2.31, showing sellers dominate intraday and pointing to oversold conditions. The stock has fallen $15.65 so far today, or 4.58%, after a downside opening gap of about 2.26%. Current price hovers near the day’s low within a $324.3 to $335.13 range, with intraday volatility at 3.34%. The technical configuration suggests continued post-open pressure alongside diverging momentum and oversold oscillators.

Previously it was reported that Astera Labs faced selling pressure following a research downgrade, despite strong revenue growth and mixed technical signals. The latest ETF-driven decline reinforces this negative momentum, with continued post-gap volatility highlighting $324.3 as an important short-term support level traders should monitor for potential further weakness.

Source of Data: ALAB Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.